Chugai Pharmaceutical Co (MEX:4519N) 5-Year Yield-on-Cost %: 0.00 (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4519N Chugai Pharmaceutical Co Ltd MEX:4519N
97 GF Score
Price MXN825.61
GF Value MXN935.38
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co 5-Year Yield-on-Cost %?

Chugai Pharmaceutical Co MEX:4519N 97 5-Year Yield-on-Cost % is 0.00 as of Aug. 23, 2026. GuruFocus rates MEX:4519N with a GF Score™ of 97/100 and a GF Value™ of MXN935.38. The stock has 1 warning sign investors should review. Among 507 Drug Manufacturers companies, Chugai Pharmaceutical Co ranks better than 67.26% on this metric.

Chugai Pharmaceutical Co's yield on cost for the quarter that ended in Jun. 2026 was 0.00.


The historical rank and industry rank for Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:


During the past 13 years, Chugai Pharmaceutical Co's highest Yield on Cost was 5.32. The lowest was 1.17. And the median was 2.75.


MEX:4519N's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.36
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Chugai Pharmaceutical Co  (MEX:4519N) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Chugai Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms


MEX:4519N vs LLY, JNJ, ABBV: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.


MEX:4519N
97GF Score
Chugai Pharmaceutical Co Ltd MEX:4519N
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Chugai Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
Chugai Pharmaceutical Co (MEX:4519N) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 23, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Chugai Pharmaceutical Co and its competitors. Over the past decade, Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % has ranged from 1.17 to 5.32. According to the industry distribution chart, Chugai Pharmaceutical Co ranks #166 out of 507 companies in the Drug Manufacturers industry, placing it in the top 32.7%.
Is Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % too high?
Chugai Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.17 to a high of 5.32. Based on the distribution chart, Chugai Pharmaceutical Co ranks #166 out of 507 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chugai Pharmaceutical Co has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's 5-Year Yield-on-Cost % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Chugai Pharmaceutical Co ranks #166 out of 507 companies for 5-Year Yield-on-Cost %. This puts Chugai Pharmaceutical Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.36. Historically, Chugai Pharmaceutical Co's own 5-Year Yield-on-Cost % has ranged from 1.17 to 5.32 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.36, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Chugai Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chugai Pharmaceutical Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Chugai Pharmaceutical Co (MEX:4519N) has a current 5-Year Yield-on-Cost % of 0.00. The stock's GF Value™ is MXN935.38, compared to a current price of MXN825.61 — trading 11.7% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Chugai Pharmaceutical Co's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Chugai Pharmaceutical Co (MEX:4519N), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (MEX:4519N) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN825.61 is trading 11.7% below its estimated GF Value™ of MXN935.38.

Key valuation signals for MEX:4519N:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: MXN935.38 vs. price of MXN825.61 (11.7% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the MEX:4519N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
97GF Score

Get the complete analysis for MEX:4519N

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN825.61
Price
MXN935.38
GF Value